Skip to main navigation
Skip to search
Skip to main content
The Capital Region of Denmark's Research Portal Home
Help & FAQ
Dansk
English
Home
Hospitals/departments
Researchers
Research output
Activities
Prizes
Search by expertise, name or affiliation
Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome
Nanna Witting
,
John Vissing
Neurology, Department of
23
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Pharmacologic treatment of downstream of tyrosine kinase 7 congenital myasthenic syndrome'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Congenital Myasthenic Syndromes
100%
Protein-Tyrosine Kinases
57%
Ephedrine
28%
Albuterol
25%
Cholinesterase Inhibitors
24%
2,4-diaminopyridine
15%
Amifampridine
11%
Therapeutics
10%
Muscle Fatigue
8%
Myasthenia Gravis
8%
Muscle Weakness
7%
Drug Combinations
7%
Age of Onset
6%
Publications
5%
PubMed
5%
Databases
4%
Mutation
3%
Pharmaceutical Preparations
2%